Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.493
Abstract: Rivastigmine has been shown to improve cognition in HIV+ patients with minor neurocognitive disorders; however, the mechanisms underlying such beneficial effect are currently unknown. To assess whether rivastigmine therapy is associated with decreased brain inflammation… read more here.
Keywords: rivastigmine; hiv patients; rivastigmine therapy; damage ... See more keywords